291.16
291.16 (0%)
As of Feb 14, 2025
Amgen Inc [AMGN]
Source:
Company Overview
Amgen Inc discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. We focus on areas of high unmet medical need and leverage our expertise to strive for solutions that dramatically improve people’s lives, while also reducing the social and economic burden of disease.
| Country | United States |
| Headquarters | thousand oaks, california |
| Phone Number | (805) 447-1000 |
| Industry | manufacturing |
| CEO | Robert A. Bradway |
| Website | www.amgen.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $33,424 |
| Operating Profit | $7,258 |
| Net Income | $4,090 |
| Net Cash | $1,029 |
Profit Ratios
| Gross Margin | $20,566 |
| Operating Margin | 21.7 |
| Profit as % of Revenues | 502.8% |
| Profit as % of Assets | 4.3% |
| Profit as % of Stockholder Equity | 69.6% |
Management Effectiveness
| Return on Equity | 69.6% |
| Return on Assets | 4.5% |
| Turnover Ratio | 35.4% |
| EBITA | $7,258 |
Balance Sheet and Cash Flow Measures
| Total Assets | $91,839 |
| Total Liabilities | $85,962 |
| Operating Cash Flow | $11,490 |
| Investing Cash Flow | $-1,046 |
| Financing Cash Flow | $-9,415 |
